Skip to main content

Strongbridge Biopharma plc

SBBPDelisted Oct 5, 2021
Industry
Pharmaceutical Preparations
SEC CIK
0001634432

Strongbridge Biopharma plc was delisted on Oct 5, 2021; its insiders filed their last Form 4 on Jan 5, 2022; 49 institutions reported holding it in 13F filings for Q3 2021, worth $69.8M in total; Fairfax Financial was the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Strongbridge Biopharma plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Strongbridge Biopharma plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Strongbridge Biopharma plc
NameTitleLast reported holdingLast filingFilings, past year
Kovner Bruce10% Owner0Jan 5, 20220
Caxton Corp10% Owner0Jan 5, 20220
CDK Associates, L.L.C.10% Owner0Jan 5, 20220
Gill David NDirector0Oct 6, 20210
Sherman Jeffrey WDirector0Oct 6, 20210
Long Stephen JChief Legal Officer0Oct 6, 20210
Johnson JohnChief Executive Officer0Oct 6, 20210
Kollender Richard SPresident and CFO0Oct 6, 20210
Kong GarhengDirector0Oct 6, 20210
Steen MartenDirector0IndirectOct 6, 20210
Steineger Hilde HDirector0Oct 6, 20210
Cohen Fredric J.Chief Medical Officer160,408Oct 6, 20210
Wilhoit Scott L.Chief Commercial Officer0Oct 6, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

No insider trades match these filters.